Jump to site navigation

Perlmutter Cancer Center Highlights

Perlmutter Cancer Center Highlights 2019–2020

Breakthrough: FDA Approves First Treatment in 22 Years for a Common Type of Bladder Cancer

Trial provides new options for bacillus Calmette-Guérin–unresponsive non-muscle invasive type.

Read Story

Explore the Issue

Browse All Issues
Current site Current page